Evidence map›Paper›PMID 37988663›Full record

ArticleArchives of endocrinology and metabolism2023

Investigation of the molecular genetic causes of non-syndromic primary ovarian ınsufficiency by next generation sequencing analysis.

Eren Er, Semih Aşıkovalı, Hatice Özışık, Elif Sağsak, Damla GÖkşen, Hüseyin Onay, Füsun Saygılı, Şükran Darcan, Samim Özen

Open access · diamondAbstract read
In one paragraph

Article in Archives of endocrinology and metabolism, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. HomozygousReproductive medicine and biology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Eren ErTepecik Training and Research Hospital, Department of Pediatric Endocrinology, Izmir, Turkey, drerener1984@gmail.com.
Semih AşıkovalıEge University Faculty of Medicine, Department of Medical Genetics, Izmir, Turkey.
Hatice ÖzışıkEge University Faculty of Medicine, Department of Endocrinology and Metabolism, Izmir, Turkey.
Elif SağsakUniversity of Health Sciences, Gaziosmanpaşa Training and Research Hospital, Clinic of Pediatric Endocrinology, Istanbul, Turkey.
Damla GÖkşenTepecik Training and Research Hospital, Department of Pediatric Endocrinology, Izmir, Turkey.
Hüseyin OnayEge University Faculty of Medicine, Department of Medical Genetics, Izmir, Turkey.
Füsun SaygılıEge University Faculty of Medicine, Department of Endocrinology and Metabolism, Izmir, Turkey.
Şükran DarcanTepecik Training and Research Hospital, Department of Pediatric Endocrinology, Izmir, Turkey.
Samim ÖzenTepecik Training and Research Hospital, Department of Pediatric Endocrinology, Izmir, Turkey.
Ege University · TRIzmir Tepecik Eğitim ve Araştırma Hastanesi · TRSağlık Bilimleri Üniversitesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: The aim of this study is to investigate the molecular genetic causes of non-syndromic primary ovarian insufficiency (POI) cases with the gene panel basedon next generation sequencing analysis and to establish the relationship between genotype and phenotype. Materials and methods: Twenty three cases aged 14-40 years followed up with POI were included. Patients with a karyotype of 46, XX, primary or secondary amenorrhea before the age of 40, with elevated FSH (>40 IU/mL) and low AMH levels (<0.03 ng/mL) were included in the study. Molecular genetic analyzes were performed by the next generation sequencing analysis method targeted with the TruSight TM Exome panel. Results: Median age of the cases was 17.8 (14.0-24.3) years, and 12 (52%) cases admitted before the age of 18. Fifteen (65%) patients had consanguineous parents. In2 (8.6%) cases, variants detected were in genes that have been previously proven to cause POI. One was homozygous variant in FIGLA gene and the other was homozygous variant in PSMC3IP gene. Heterozygous variants were detected in PROK2, WDR11 and CHD7 associated with hypogonadotropic hypogonadism, but these variants are insufficient to contribute to the POI phenotype. Conclusion: Genetic panels based on next generation sequencing analysis technologies can be used to determine the molecular genetic diagnosis of POI, which has a highly heterogeneous genetic basis.

Indexed as

Primary Ovarian InsufficiencyAdolescentAdultFemaleGenotypeHigh-Throughput Nucleotide SequencingHumansMolecular BiologyNuclear ProteinsPhenotypeTrans-ActivatorsYoung AdultNuclear ProteinsPSMC3IP protein, humanTrans-Activatorscandidate genesnext generation sequencing analysisPrimary ovarian insufficiency

Identifiers

PMID37988663
PMCPMC10916837
OpenAlexW4388921900

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.